BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8027926)

  • 1. Comparative study of buccoadhesive formulations and sublingual capsules of nifedipine.
    Save T; Shah MU; Ghamande AR; Venkitachalam P
    J Pharm Pharmacol; 1994 Mar; 46(3):192-5. PubMed ID: 8027926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule.
    Myers MG; Raemsch KD
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S76-8. PubMed ID: 2455148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic comparisons of oral and sublingual nifedipine in hypertensive Mexican patients.
    Palma-Aguirre JA; Roa-Mendieta A; Hernández-Jiménez LM; Girard-Cuesy ME; León-Urrea F; Alfaro-Mejía A; Frati A; Barreiro-Perera O
    Proc West Pharmacol Soc; 1993; 36():137-41. PubMed ID: 8378367
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of sublingual captopril and sublingual nifedipine in hypertensive emergencies.
    Ceyhan B; Karaaslan Y; Caymaz O; Oto A; Oram E; Oram A; Ugurlu S
    Jpn J Pharmacol; 1990 Feb; 52(2):189-93. PubMed ID: 2179605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal of nifedipine capsules: jeopardising the treatment of acute severe hypertension in pregnancy?
    Langton PE
    Med J Aust; 1998 Jan; 168(1):43-4. PubMed ID: 9451398
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the method for nifedipine administration for a rapid onset of clinical effect: a clinical study in normal volunteers.
    Kubota R; Komiyama T; Shimada H
    Yakugaku Zasshi; 2001 May; 121(5):355-64. PubMed ID: 11360489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sublingual captopril, nifedipine and prazosin in hypertensive emergencies during hemodialysis.
    Wu SG; Lin SL; Shiao WY; Huang HW; Lin CF; Yang YH
    Nephron; 1993; 65(2):284-7. PubMed ID: 8247194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual nicardipine versus nifedipine to treat hypertensive urgencies.
    Savi L; Montebelli MR; D'Alonzo S; Mettimano M; Folli G
    Int J Clin Pharmacol Ther Toxicol; 1992 Feb; 30(2):41-5. PubMed ID: 1551744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hypertensive emergencies with nifedipine.
    Karachalios GN; Donas G; Tsimiklis S; Stathakakis V
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):351-5. PubMed ID: 3209283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial.
    Angeli P; Chiesa M; Caregaro L; Merkel C; Sacerdoti D; Rondana M; Gatta A
    Arch Intern Med; 1991 Apr; 151(4):678-82. PubMed ID: 2012448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sublingual captopril versus nifedipine in the treatment of hypertensive crisis].
    Pérez C; Dougnac A; Alvarez M; Andresen M; Díaz O; Geni R; Prat G; Vásquez M
    Rev Med Chil; 1991 Apr; 119(4):402-5. PubMed ID: 1842983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
    Grossman E; Messerli FH; Grodzicki T; Kowey P
    JAMA; 1996 Oct 23-30; 276(16):1328-31. PubMed ID: 8861992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and dynamics of nifedipine after oral and sublingual doses.
    McAllister RG
    Am J Med; 1986 Dec; 81(6A):2-5. PubMed ID: 3799661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
    Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypertensive emergencies and crisis with sublingual nifedipine].
    Domínguez B; Díaz R
    Rev Med Panama; 1988 May; 13(2):100-6. PubMed ID: 3194548
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study of the acute antihypertensive effect of Adalat capsules and Corinfar dragées, two different nifedipine preparations.
    Kiss I; Farsang C
    Cor Vasa; 1988; 30(2):105-9. PubMed ID: 3391034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual and intravenous ketanserin versus sublingual nifedipine in the treatment of severe hypertension: a randomized study.
    Sechi LA; Tedde R; Cassisa L; Pala A; Orecchioni C; Uneddu F; Melis A
    Clin Ther; 1989; 11(6):834-40. PubMed ID: 2692825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertensive crisis: comparative study of oral captopril, sublingual captopril and sublingual nifedipine].
    Martínez Amenós A; Carratalà J; Pintó X; Santaló M; Tamayo C; Pujol M
    Med Clin (Barc); 1987 Jun; 89(2):59-61. PubMed ID: 3302561
    [No Abstract]   [Full Text] [Related]  

  • 20. Negligible sublingual absorption of nifedipine.
    van Harten J; Burggraaf K; Danhof M; van Brummelen P; Breimer DD
    Lancet; 1987 Dec; 2(8572):1363-5. PubMed ID: 2890954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.